Skip to content

Author

Olivia Kim-Mcmanus

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Individualized antisense oligonucleotides for SCN2A-related developmental epileptic encephalopathy

In two patients with SCN2A epileptic encephalopathy, treatment with personalized allele-selective antisense oligonucleotides led to a decrease in seizure frequency with a positive safety profile, and a pathway from n = 1 to n of more patients with SCN2A-RD and other monogenic disorders is provided.

Olivia Kim-Mcmanus, L. Mignon, J. Douville et al. · 2 citations